Rogers Corp.

  • Market Cap: Small Cap
  • Industry: Specialty Chemicals
  • ISIN: US7751331015
USD
87.20
-0.67 (-0.76%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Rogers Corp. stock-summary
stock-summary
Rogers Corp.
Specialty Chemicals
Rogers Corporation manufactures and sells engineered materials and components for mission critical applications. The Company's segments are Advanced Connectivity Solutions (ACS), Elastomeric Material Solutions (EMS), Power Electronics Solutions (PES) and Other. The ACS segment manufactures and sells circuit materials and solutions for applications in wireless communications infrastructure, automotive, connected devices, consumer electronics and aerospace/defense. The EMS segment manufactures and sells elastomeric material solutions for critical cushioning, sealing, impact protection and vibration management applications, including general industrial, portable electronics, consumer goods, automotive, construction and printing applications. The PES segment manufactures and sells ceramic substrate materials for power module applications, laminated bus bars for power inverter and interconnect applications, and micro-channel coolers. Its other business consists of elastomeric components.
Company Coordinates stock-summary
Company Details
2225 W Chandler Blvd , CHANDLER AZ : 85224-6155
stock-summary
Tel: 1 480 9176000
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 76 Schemes (49.87%)

Foreign Institutions

Held by 109 Foreign Institutions (19.36%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Bruce Hoechner
President and Chief Executive Officer, Principal Executive Officer and Director
Mr. Peter Wallace
Lead Independent Director
Ms. Megan Faust
Director
Mr. Keith Larson
Director
Mr. Keith Barnes
Independent Director
Ms. Carol Jensen
Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
203 Million
(Quarterly Results - Jun 2025)
Net Profit:
-74 Million
stock-summary
Industry

Specialty Chemicals

stock-summary
Market cap

USD 1,422 Million (Small Cap)

stock-summary
P/E

27.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.13

stock-summary
Return on Equity

3.25%

stock-summary
Price to Book

1.18